United States-Israel Agriculture Cooperation Improvement and Expansion Act
- Sponsor
- Sen. Hoeven, John [R-ND]
- Committees
- Foreign Relations Committee (primary)
- Last action
- Jun 22, 2026
Bottom line
The bill expands the scope and funding for the successful U.S.-Israel Binational Agricultural Research and Development Fund to accelerate agricultural innovation from mid-stage research to market.
What it actually does
This bill amends the National Agricultural Research, Extension, and Teaching Policy Act of 1977 to expand the mission of the United States-Israel Binational Agricultural Research and Development Fund (BARD Fund). It specifically adds support for mid-stage research and establishes a new 'BARD Fund accelerator' program to fast-track cooperative research and commercialization. The bill also authorizes $8,000,000 for each of fiscal years 2027 through 2031 for these expanded activities.
Proponents argue
Supporters argue that this bill builds upon the proven success of the BARD Fund, which has generated significant returns on investment and fostered critical agricultural advancements. By focusing on mid-stage research and establishing an accelerator, proponents believe the bill will bridge the gap between early-stage discoveries and commercial application, bringing innovations to market faster and strengthening both U.S. and Israeli economies and food security.
Opponents contend
Critics, if any, might raise concerns about new federal spending commitments, particularly during periods of fiscal constraint, or question the necessity of creating a new accelerator program if existing mechanisms could be leveraged. However, given the BARD Fund's history of high returns and bipartisan support for U.S.-Israel cooperation, widespread opposition is unlikely.
The bill is very short and clearly written, making it highly accessible for a reader to understand its provisions and implications quickly.
Section 3(2)(C)
Expansion of BARD Fund Mission to Include Mid-Stage Research
This provision modifies the existing mandate of the BARD Fund to explicitly include supporting 'mid-stage research' aimed at advancing cooperative agricultural projects between the United States and Israel. Previously, the fund focused broadly on collaborative agricultural research; this amendment specifies a focus on a particular stage of research development, intending to bridge the gap between basic research and commercialization.
Supporters argue
Supporters argue that focusing on mid-stage research is crucial for translating scientific discoveries into practical applications. This targeted support will help overcome the 'valley of death' in innovation, where promising research often stalls due to lack of funding for development and scaling.
Critics contend
No specific opposition is typically raised against this provision, as it is seen as a logical extension of the BARD Fund's mission to enhance agricultural innovation. Some might generally question the allocation of resources to specific research stages, but not the principle itself.
Tradeoffs
The primary tradeoff is the potential for resources to be diverted from early-stage, foundational research if not managed carefully. However, proponents believe the overall benefit of accelerating innovation outweighs this risk by creating a more complete research pipeline.
Section 3(3)
Establishment of BARD Fund Accelerator Program
This provision mandates the BARD Fund to establish an 'accelerator program' specifically designed to support mid-stage research. The accelerator will fast-track cooperative research, provide resources and services (like management guidance, technical assistance, and consulting) to scientists, and generally advance U.S.-Israel agricultural research projects. The program aims to expedite the successful development of agricultural innovations.
Section 3(4)
Authorization of Appropriations for BARD Fund Activities
This provision authorizes the appropriation of $8,000,000 for the BARD Fund for each of fiscal years 2027 through 2031. This funding is specifically designated to carry out the expanded activities under the modified subsection, including the new mid-stage research focus and the accelerator program. This ensures a dedicated financial commitment to the bill's objectives.